1 year return (CAGR)
21.40%
Viridian Therapeutics Inc Exchange (NASDAQ, USD)
VRDN
21.24
-0.66 (-3.75%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-10.89%
5 year return (CAGR)
-0.62%
10 year return (CAGR)
-17.17%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.75B
Price/Sales
24.67
Ent value
1.71B
Price/Book
2.42
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-33.53%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 17.50 |
| Daily high | 17.60 |
| Daily low | 16.60 |
| Daily Volume | 1.28M |
| All-time high | 1901.25 |
| 1y analyst estimate | 36.63 |
| Beta | 0.96 |
| EPS (TTM) | -3.59 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| VRDN | S&P500 | |
| Current price drop from All-time high | -98.88% | -1.75% |
| Highest price drop | -99.71% | -56.47% |
| Date of highest drop | 19 Mar 2020 | 9 Mar 2009 |
| Avg drop from high | -93.69% | -10.69% |
| Avg time to new high | 1502 days | 12 days |
| Max time to new high | 3002 days | 1805 days |
News
